Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 8—August 2024
Dispatch

Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017–2023

Tsung-Hua Wu, Yu-Ping Fang, Fang-Ching Liu, Hui-Hsien Pan, Yu-Ying Yang, Chiah-Sing Song, and Chun-Yi LeeComments to Author 
Author affiliations: Show Chwan Memorial Hospital, Changhua, Taiwan (T.-H. Wu, Y.-Y. Yang); College of Medicine, National Chung Hsing University, Taichung, Taiwan (T.-H. Wu, C.-Y. Lee); Chang Bing Show Chwan Memorial Hospital, Changhua (Y.-P. Fang, C.-S. Song, C.-Y Lee); Jen-Ai Hospital, Taichung (F.-C. Liu); Taichung Veterans General Hospital, Taichung (H.-H. Pan)

Main Article

Table 2

Distribution of macrolide susceptibility of sequence type 3 and 17 isolates in a study of macrolide-resistant Mycoplasma pneumoniae infections among children before and during the COVID-19 pandemic, Taiwan, 2017–2023

Macrolide susceptibility
 Year, no. (%) isolates
2017
 2018
 2019
 2020
 2021
 2022
 2023
Sequence type 3
Resistant 6 (50) 17 (70.8) 13 (72.2) 0 0 0 0
Susceptible 6 (50) 7 (29.2) 5 (27.8) 0 6 (100) 3 (100) 17 (100)
Total no. isolates
 12
 24
 18
 0
 6
 3
 17
Sequence type 17
Resistant 0 3 (21.4) 1 (14.3) 2 (66.7) 0 0 0
Susceptible 14 (100) 11 (78.6) 6 (85.7) 1 (33.3) 2 (100) 0 0
Total no. isolates 14 14 7 3 2 0 0

Main Article

Page created: June 24, 2024
Page updated: July 21, 2024
Page reviewed: July 21, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external